Nearly 4,000 participants came together on May 31 for We Walk UHNITED presented by Rogers, UHN Foundation's newest ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Ameda, a leader in hospital-grade breast pump innovation, proudly announces the launch of the Ameda GLOtm Wearable Breast Pump, a compact, powerful, and truly hands-free solution designed with ...

At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...

Dr. Alan Bryce presented the preliminary results from a phase II trial of PT-112 monotherapy in late-line metastatic castration-resistant prostate cancer (mCRPC). Late-line mCRPC patients have poor ...